Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
01 October 2021Website:
http://nutriband.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
pre-market | Mon, 01 Jul 2024 13:17:14 GMTDividend
Analysts recommendations
Institutional Ownership
Similar companies
What type of business is Nutriband?
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
What sector is Nutriband in?
Nutriband is in the Healthcare sector
What industry is Nutriband in?
Nutriband is in the Biotechnology industry
What country is Nutriband from?
Nutriband is headquartered in United States
When did Nutriband go public?
Nutriband initial public offering (IPO) was on 01 October 2021
What is Nutriband website?
http://nutriband.com
Is Nutriband in the S&P 500?
No, Nutriband is not included in the S&P 500 index
Is Nutriband in the NASDAQ 100?
No, Nutriband is not included in the NASDAQ 100 index
Is Nutriband in the Dow Jones?
No, Nutriband is not included in the Dow Jones index
When does Nutriband report earnings?
Next earnings report date is not announced yet